Vasculitis Symptoms, Doctors, Treatments, Advances & More

Learn About Vasculitis

What is the definition of Vasculitis?

Vasculitis is considered to be an autoimmune disease wherein the immune system causes inflammation of the blood vessels. The disease can be acute or chronic. There are many types of vasculitis, which mainly occurs in rare diseases. Vasculitis causes changes in blood vessels which decrease blood flow and oxygen to body tissues and vital organs. While the causes of vasculitis are often unknown, it can occur after an infection, another disease, or a reaction to medication when the immune system is triggered and attacks the vascular system. Genetics may also be a factor.

Save information for later

What are the symptoms of Vasculitis?

Signs and symptoms of vasculitis can vary but include red spots, lumps, or sores on the skin, rash, nerve problems (which may cause numbness or weakness in hands and feet), cough and difficulty breathing, fever, weight loss, and fatigue.

Not sure about your diagnosis?

Check Your Symptoms

What are the current treatments for Vasculitis?

The treatment depends on the type of vasculitis, with the goal of stopping the inflammation. While some vasculitis may improve without treatment, some types require steroids, immunosuppressive drugs such as cyclophosphamide, methotrexate, azathioprine, newer drugs such as rituximab, or surgery.

Who are the top Vasculitis Local Doctors?

Christian Pagnoux

Elite

Highly rated in

conditions

Mount Sinai Hospital

Toronto, ON, CA

Christian Pagnoux practices in Toronto, Canada. Pagnoux is rated as an Elite expert by MediFind in the treatment of Vasculitis. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Vasculitis, Granulomatosis with Polyangiitis, Necrotizing Vasculitis, and Microscopic Polyangiitis.

Benjamin Terrier

Elite

Highly rated in

conditions

Hôpitaux Cochin - Port Royal

Paris, FR

Benjamin Terrier practices in Paris, France. Terrier is rated as an Elite expert by MediFind in the treatment of Vasculitis. He is also highly rated in 47 other conditions, according to our data. His top areas of expertise are Vasculitis, Granulomatosis with Polyangiitis, Cryoglobulinemia, Necrotizing Vasculitis, and Kidney Transplant.

Learn about our expert tiers

Learn more

David W. Jayne

Elite

Highly rated in

conditions

University Of Cambridge- Addenbrookes Hospital

Cambridge, GB

David Jayne practices in Cambridge, United Kingdom. Jayne is rated as an Elite expert by MediFind in the treatment of Vasculitis. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Vasculitis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Kidney Transplant, and Endoscopy.

View All Doctors

What are the latest Vasculitis Clinical Trials?

A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind, Proof-of-Concept Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis

Who is this study for: Patients with Giant Cell Arteritis

Enrollment Status: Recruiting

Publish Date: February 15, 2023

Intervention Type: Drug

Study Drug: Guselkumab

Study Phase: Phase 2

Summary: The primary purpose of this study is to evaluate the efficacy of guselkumab compared to placebo, in combination with a 26-week glucocorticoid (GC) taper regimen, in adult participants with new-onset or relapsing giant cell arteritis (GCA).

Match to trials

Find the right clinical trials for you in under a minute

Get started

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica

Enrollment Status: Recruiting

Publish Date: February 15, 2023

Intervention Type: Drug

Study Phase: Phase 3

Summary: Polymyalgia rheumatica (PMR) is prevalent among elderly. Untreated, it leads to major reduction in quality of life. Glucocorticoids are the cornerstone of treatment, but have drawbacks, warranting glucocorticoid sparing treatment. A proof of concept study on Rituximab (RTX) vs placebo showed efficacy in 48 vs 21%(p=0.049) in glucocorticoid free remission after 21 weeks (Marsman et al. 2021). Thoug...

View All Clinical Trials

What are the Latest Advances for Vasculitis?